Last Friday, the U.S. Food and Drug Administration (FDA) held its first public hearing about the safety and regulation of cannabis and cannabis-derived products. At the heart of the hearing were issues of how the FDA should regulate CBD, which has been growing in popularity as both a nutritional supplement and as a patented […]

The post FDA Public Hearing About CBDs Prescribes Caution, Bearishness, and Deliberation appeared first on Hemp Business Journal.